Workflow
中美禁毒合作
icon
Search documents
中欧领导人会晤是否将于下周举行?外交部回应
证券时报· 2025-07-17 09:03
中欧领导人会晤是否将于下周举行?外交部回应 据环球网,在17日的外交部例行记者会上,有媒体提问称,外交部能否确认中欧领导人会晤是否将于下周举行,并提供相关细节? 外交部发言人林剑7月17日主持例行记者会。 对此,外交部发言人林剑表示,目前我没有可以提供的信息。 中俄印正就恢复三方合作机制谈判?外交部回应 有媒体提问称,俄罗斯外交部副部长鲁登科正与中国和印度就恢复三方合作机制进行谈判,他称俄罗斯对推动该机制的运作保持积极态度,请问中方对此有 何评论? 对此,林剑表示,中俄印合作不仅符合三国的自身利益,也有利于地区乃至全球和平安全稳定与进步。中方愿同俄印双方就推进中俄印合作保持沟通。 外交部:芬太尼是美国的问题,不是中国的问题,责任在美国自身 据媒体报道,美国总统特朗普16日称,他认为中国很快会对制造和分销毒品芬太尼的人员判处死刑,他对与北京就非法毒品问题达成协议的前景感到乐观。 对此,林剑17日在外交部例行记者会上回应相关问询时表示,我们多次表明,芬太尼是美国的问题,不是中国的问题,责任在美国自身。美方无视中方的善 意,执意对中国加征芬太尼关税,这严重冲击中美在禁毒领域的对话与合作,也严重损害中方利益。美国如果 ...
外交部回应特朗普涉芬太尼言论:美方应以平等、尊重、互惠方式同中方对话
news flash· 2025-07-17 07:23
外交部回应特朗普涉芬太尼言论:美方应以平等、尊重、互惠方式同中方对话 金十数据7月17日讯,7月17日,外交部发言人林剑主持例行记者会。针对特朗普涉芬太尼言论,林剑表 示,我们多次表明芬太尼是美国的问题,不是中国的问题,责任在美国自身。美方无视中方的善意,执 意对中国加征芬太尼关税,这严重冲击中美在禁毒领域的对话与合作,也严重损害中方利益。"美国如 果真心想同中国合作,就应正视客观事实,以平等、尊重、互惠的方式同中方对话。"林剑说。 (澎 湃) ...
伯恩斯称若中方不协调芬太尼问题就要付出代价,外交部驳斥
news flash· 2025-05-14 07:40
Core Viewpoint - The Chinese government asserts that the fentanyl issue is primarily an American problem and criticizes the U.S. for imposing tariffs on fentanyl, which disrupts dialogue and cooperation in drug control between the two countries [1] Group 1 - The Chinese Foreign Ministry emphasizes that fentanyl is a U.S. issue, not a Chinese one, and holds the U.S. responsible for the problem [1] - The imposition of tariffs by the U.S. on fentanyl is viewed as a serious disruption to China-U.S. cooperation in drug control efforts [1] - The Chinese government calls for a dialogue based on equality, respect, and mutual benefit, urging the U.S. to stop its negative rhetoric towards China [1]
外交部:美对华加征芬太尼关税严重冲击中美在禁毒领域对话与合作
第一财经· 2025-05-13 06:45
据央视新闻消息,5月13日,外交部发言人林剑主持例行记者会。有记者就美国对中国加征芬太尼关 税提问。 美方如果真心想同中方合作,就应该停止对华抹黑推责,以平等、尊重、互惠的方式同中方对话。 林剑表示,中方已多次表明芬太尼是美国的问题,不是中国的问题,责任在美国自身。美方无视中方 的善意,对中国无理加征芬太尼关税,这严重冲击中美在禁毒领域的对话与合作,也严重损害中方利 益。 ...
美以芬太尼为借口滥施关税,纯属“内病外治”(钟声)
Ren Min Ri Bao· 2025-04-26 21:58
Core Viewpoint - The recent comments by a U.S. mayor about distributing fentanyl to the homeless highlight the severity of the fentanyl crisis in the U.S., which is often blamed on China, undermining cooperation in drug control between the two nations [1][4]. Group 1: U.S. Fentanyl Crisis - The U.S. has not permanently classified fentanyl, leading to worsening drug abuse and overdose issues, with synthetic opioids causing 75,000 overdose deaths in 2023, accounting for nearly 70% of all drug overdose deaths [2]. - The U.S. consumes 80% of the world's opioids despite having less than 5% of the global population, indicating a significant public health crisis [2]. - A poll by the Sihe Zhiyuan Foundation shows that most Americans believe drug cartels, users, and the government are responsible for the fentanyl crisis, suggesting a need for comprehensive policy reform [2]. Group 2: China's Drug Control Efforts - China maintains a "zero tolerance" policy towards drugs, including fentanyl, and has taken significant steps in drug control, including the comprehensive classification of fentanyl in 2019, making it the first country to do so [3]. - Since China's classification of fentanyl, there have been no reported cases of fentanyl smuggling from China to the U.S., as acknowledged by the U.S. State Department [3]. - China continues to enhance its control over precursor chemicals and collaborates with countries like the U.S. and Mexico to combat the issue of fentanyl and its precursors [3]. Group 3: U.S.-China Cooperation - The establishment of the U.S.-China drug control cooperation working group in 2024 provides a platform for both countries to address global drug issues collaboratively [4]. - Ongoing technical exchanges and regular communication between the two nations' drug enforcement agencies aim to strengthen cooperation in tackling the fentanyl crisis [4]. - China's strong opposition to the U.S. imposing tariffs under the pretext of the fentanyl issue emphasizes the need for mutual respect and factual acknowledgment in bilateral relations [4].
公安部回应美方威胁再加征
券商中国· 2025-02-28 15:39
Core Viewpoint - The Chinese government expresses strong dissatisfaction and firm opposition to the U.S. threat of imposing an additional 10% tariff on Chinese products, citing the fentanyl issue as the reason [1]. Group 1 - The U.S. plans to impose tariffs starting March 4, using the fentanyl crisis as a pretext, which China views as an unjustified action [1]. - China emphasizes its strict drug control policies and international cooperation efforts in combating drug issues, asserting that it has made significant contributions to addressing the fentanyl problem [1]. - The root cause of the fentanyl crisis is identified as domestic issues within the U.S., and China urges the U.S. to focus on reducing domestic drug demand and enhancing law enforcement cooperation [1]. Group 2 - The Chinese government warns that the U.S. approach of shifting blame to other countries will not resolve the underlying issues and could severely impact Sino-U.S. cooperation in drug control [1]. - China calls for the U.S. to correct its erroneous actions and to maintain the positive momentum of bilateral drug control cooperation, which has been hard-won [1].